May 24, 2024
Urea Breath Test

Urea Breath Test Market Is Estimated To Witness High Growth Owing To Increased Adoption Of Non-Invasive Diagnostic Tests

The urea breath test market has gained significant traction in recent years owing to the growing prevalence of Helicobacter pylori infection and increasing adoption of minimally invasive diagnostic tests for gastrointestinal disorders. A urea breath test is a non-invasive diagnostic procedure for detecting active H. pylori infection by measuring the amount of carbon-14 labeled urea in a breath sample after administration of a capsule or liquid containing this urea. It is highly accurate and avoids the need for invasive endoscopy.

The global urea breath test market is estimated to be valued at US$ 140.8 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2030.

Key Takeaways

Key Players: Key players operating in the urea breath test market are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar Hay, Green Prairie International, Grupo Osés, Gruppo Carli, Hay USA, Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and Standlee Hay Company.

Key Opportunities: Rising awareness about H. pylori infections and advantages of Urea Breath Test Market Growth over invasive endoscopy procedures are expected to create significant growth opportunities for players in the urea breath test market.

Global Expansion: Leading manufacturers are focusing on expanding their geographical presence in high growth regions such as Asia Pacific and Latin America. Strategic partnerships with local players in developing nations will further aid global expansion plans.

Market Drivers

Increased adoption of minimally invasive diagnostic tests: The non-invasive nature of urea breath tests makes them preferred first-line diagnostic options over endoscopies for suspected H. pylori infections. This is a major factor driving increased adoption.

Growing disease prevalence: Rising prevalence of peptic ulcer disease and gastric cancer attributed to H. pylori is leading to higher testing rates, fueling demand for urea breath tests. The global disease prevalence is expected to increase over 6.6% during the forecast period.

PEST Analysis

Political: Regulations around manufacturing, quality control, safety and ethics will impact the development and use of urea breath tests. Government investments in healthcare can influence demand.
Economic: Growth in disposable income increases ability to pay for diagnostic testing. Cost of raw materials and manufacturing impact business models.
Social: Awareness of health issues like H. pylori infections drive testing. Demographic trends like aging populations influence diagnostic needs.
Technological: Advances in ingredients, formulations and production methods can improve accuracy and drive costs down enhancing adoption. Digitization of medical records aids test interpretation and tracking.

The geography where the urea breath test market is most concentrated in terms of value is North America. The region has established healthcare systems and widespread diagnostic testing. Growing disease awareness and an aging population also contribute to significant demand.

The fastest growing region for the urea breath test market between 2024-2030 is expected to be Asia Pacific. Rising incomes are improving access to healthcare across developing nations. At the same time, changing diets and lifestyles are contributing to increased rates of conditions like H. pylori infections. Significant investments to strengthen healthcare infrastructure also offer opportunities for diagnostic technologies in the region over the forecast period.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it.